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Introduction
Despite the scientific advances in reproductive 
medicine during the last years, recurrent implantation 
failure (RIF) remains a challenging and extremely 
disappointing problem for the clinicians and patients 
(Potdar et al., 2012). It is defined as failure to achieve 
a clinical pregnancy after the transfer of at least four 
good-quality embryos (minimum of three fresh or 
frozen cycles) (Coughlan et al., 2014). Other authors 
define RIF as the impossibility to achieve conception 
after 2 to 6 IVF cycles (with high-quality embryos) 
(Dalton et al., 2006). The successful outcome of a 
pregnancy depend on several factors, among which 
embryo quality and intrauterine environment play 
major roles. Both factors allow for the achievement 
and continuation of gestation (Raju et al., 2006; 
Ghahiry et al., 2014). Attention has recently focused 
on the anatomical integrity of the uterine cavity, as a 
prerequisite for a receptive endometrium (Saravelos 
et al., 2008; Di Spiezo Sardo et al., 2015). Indeed, 
several benign uterine conditions, including 
Müllerian anomalies, may explain low pregnancy 
rates in assisted reproductive technology (ART) 
(Urman et al., 2005; Bozdag et al., 2008). 
The uterus is formed from the paramesonephric 
ducts, called Müllerian ducts, at around 8–16 weeks 
of fetal life. This process comprises three stages: (i) 
the organogenesis, or the development of the two 
Müllerian ducts; (ii) lateral fusion, in which the 
lower part of Müllerian ducts merges and forms the 
upper part of the vagina, cervix, and uterus. Lastly, 
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Background: The aim of this study was to assess the reproductive outcomes of women with recurrent implantation 
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The mean time to pregnancy was 6.5 months.
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taken carefully as this is an observational study. A prospective, randomized and controlled study is necessary to 
support these results.
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lining responsible for low implantation rates (Chan 
et al., 2011). Several studies have shown that 
metroplasty (using microscissors, electrosurgery 
or laser) improves the reproductive outcome of 
infertile women, independently from the subtype 
of the malformation (Fedele et al., 1993; Pabaçcu 
and Gomel, 2004; Zlopasa et al., 2007; Bakas 
et al., 2012). Therefore, compared to abdominal 
approaches, metroplasy is nowadays considered 
the first therapeutic option to treat dysmorphic 
uteri. Some authors recommend it in patients with 
recurrent pregnancy loss and premature labor to 
improve obstetric outcomes, as besides considered 
safe to perform, it offers advantages such as shorter 
operating time and hospitalization (Pabaçcu and 
Gomel, 2004; Bakas et al., 2012). However, it is not 
yet entirely clear whether hysteroscopic metroplasty 
used in patients with RIF and dysmorphic uteri may 
improve their reproductive outcomes.
Thus, this retrospective, observational study 
evaluates the reproductive outcomes of women with 
recurrent implantation failure after hysteroscopic 
metroplasty. For this, we adjusted the morphology 
of the uterine cavity for dysmorphic uteri. 
(ii) the reabsorption of the septum that is formed 
after the fusion of Müllerian ducts. This reabsorption 
begins at 9 weeks leaving a single central cavity 
and cervical canal (Saravelos et al., 2008). Hence, 
uterine malformations may result from disturbance 
in the developmental process of the Müllerian ducts 
or from fusion failure (Ribeiro et al., 2009).
Recurrent miscarriage is diagnosed in women 
with congenital uterine anomalies (Serensen, 1988; 
Kupesic, 2001). It is not easy to determine the actual 
incidence of uterine malformations in the general 
population because most affected women do not present 
reproductive problems (Valle and Ekpo, 2013). For 
some authors, an arcuate uterus is the most common 
in both, the general and recurrent miscarriage 
populations. For others, a septate uterus is the most 
common on those with infertility (Raga et al., 1997; 
Saravelos et al., 2008). However, according to an 
earlier study of Saravelos [Saravelos et al., 2008], 
the prevalence of congenital Müllerian anomalies 
in the general population would be around 6.7%, 
whereas in the infertile population this percentage 
attains 7.3% and up-to 16.7% in women facing 
recurrent miscarriages (Saravelos et al., 2008).  
In this instance, different approaches to classify 
and manage uterine malformations have been 
proposed (Valle and Ekpo, 2013; Ludwin and 
Ludwin, 2015). The European Society of Human 
Reproduction and Embryology (ESHRE) and the 
European Society for Gynaecological Endoscopy 
(ESGE) created the Congenital Uterine Anomalies 
Group (CONUTA) stating  a new classification 
system for uterine anomalies based on a simple 
anatomical classification (Grimbizis et al., 2013; 
Sardo et al., 2015). A Class U1 (dysmorphic uterus) 
integrates all uteri with a normal outline but with an 
abnormal uterine cavity shape (excludes septa). This 
Class U1 can be subdivided into three categories: 
(i) Class U1a (T-shaped uterus), described by 
thickened lateral walls with a correlation 2/3 uterine 
corpus and 1/3 cervix that narrow the uterine cavity; 
(ii) Class U1b (uterus infantilis), also characterized 
by a narrow uterine cavity without lateral wall 
thickening and an inverse correlation (1/3 uterine 
body and 2/3 cervix); and (iii) Class U1c (others), 
containing all minor malformations of the uterine 
cavity (Grimbizis et al., 2013). 
Also, the American Society for Reproductive 
Medicine (ASRM) proposed its classification in 
1988. The later has been widely used and includes 
T-shaped uteri into the Class VII, relating its cause 
to diethylstilbestrol-related (DES) exposure (The 
American Fertility Society, 1988; Valle and Sciarra, 
1988; Saravelos et al., 2008; Ludwin and Ludwin, 2015).
It is assumed that malformed uteri-derived 
infertility is caused by an altered endometrial 
Figure 2
Figure 1: A- Normal cavity B- T shape uterus.
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Materials and Methods
Patients 
One hundred ninety women, aged between 25 – 
48 years old (mean, 36.8), presenting recurrent 
implantation failure (defined for this study as ≥ 5 pre-
embryos transferred), and posterior hysteroscopic 
diagnosis of a dysmorphic uterus [including 
T-shaped uteri] were consecutively analyzed in 
this study. The duration of infertility in the patient 
cohort ranged from 1 to 15 years (mean, 4.3 years). 
The primary objective of the investigation was 
the assessment of the reproductive outcome after 
hysteroscopic metroplasty concerning the live-birth 
rate. For this, firstly, a complete history, thorough 
clinical examination and an exhaustive infertility 
investigation was completed. The later included 
semen analysis, endocrine evaluation, ovulation 
assessment and diagnostic imaging. Transvaginal 
ultrasound was performed to assess the pelvic, 
uterine and ovarian morphology and anatomy. The 
initial diagnosis of the dysmorphic uterus was made 
by hysteroscopy. Informed consent from all patients, 
regarding the present study and metroplasty, was 
obtained before every procedure. In all cases, the 
surgical procedure was performed under general 
anesthesia, during the early proliferative phase 
of the cycle and by the same surgeon (J.F.). 
For consistency, this study also documents the 
implantation rate, pregnancy rate, abortion and 
intrauterine death rate.
Approval from the Institutional Research Ethical 
Committee and the review board was obtained 
before the initiation of the study. This retrospective 
observational study took place between January 
2008 and September 2015 at the Instituto Valenciano 
de Infertilidad (IVI) in Valencia, Spain.
Metroplasty
Metroplasty was performed with a 4.2-mm 
hysteroscope and a 30° telescope. An additional 
external sheath, for continuous flow, and a 5-French 
work channel, for the use of both, scissors and 
bipolar electrodes was mounted (Karl Storz, 
Tuttlingen, Germany). The uterine cavity was 
distended with normal saline solution (0.9%) at an 
inflow pressure of 70–100 mm Hg. To guarantee 
minimal systemic absorption during surgery and 
early recognition of excess fluid deficit, inflow and 
outflow fluid volumes were measured (Worldwide 
AAMIG, 2013). There were no patients with fluid 
deficit of more than 2000 ml.
The endocervical canal was inspected at the 
beginning of the procedure. Once inside the uterine 
cavity, a systematic examination was performed by 
a general evaluation of the uterine cavity starting 
from the isthmic region. Then, an assessment of 
the uterine fundus, the side walls, the anterior and 
posterior walls, horns and tubal ostia was performed.
If a dysmorphic cavity was diagnosed, 
hysteroscopic metroplasty was performed, with 
microscissors and a high-frequency bipolar electrode 
[with further selective coagulation of bleeding 
vessels] in the same session. The surgical procedure 
consisted in performing an incision (or straight cuts) 
at the level of the prominent lateral myometrial walls 
and to widen it after the incision. Nine and three 
hours from the isthmic region and in the direction 
towards the tubal orifices were used as guides. The 
operation was considered complete when the tubal 
orifices were seen from the isthmic area of the body, 
the hysteroscope could be moved freely from one 
tubal ostium to the other, and a normal uterine cavity 
of triangular aspect was obtained. Many of these 
uteri also had some degree of a fundal notch. These 
required remodeling with scissors. Autocross-linked 
hyaluronic acid (Hyalobarrier©, Fidia Advanced 
Biopolymers SRL, Padova, Italy) was introduced 
in the uterine cavity after surgery as a mechanical 
barrier between the uterine walls thus preventing the 
formation of adhesions (Ferro and Montoya, 2016). 
Postoperative Measures 
In the same day, four to six hours after the procedure, 
treated patients were discharged. All patients 
received one dose of azithromycin orally (1 gr), 
analgesia with paracetamol and hormonal therapy 
(oestradiol valerate - levonorgestrel) for twenty-
one days. In one hundred eighty patients (94.7%), a 
second-look hysteroscopy was performed after the 
first deprivation bleeding. Women were evaluated 
on the first postoperative day and returned for a 
Figure 2: Metroplasty: A — Cut in the prominent fundus of cavity in uterus T shape, like fundus of arcuate cavity. B — Cut in lateral 
right wall of the uterine cavity. C — Cut in lateral left wall of the uterine cavity.D — Panoramic view of metroplasty.
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months of follow-up. A Kaplan-Meier analysis plot 
for the probability to achieve pregnancy per month 
related to total follow-up time is presented in Figure 1.
No ectopic pregnancies or stillbirths were 
recorded. Thirty-four out of 152 pregnant women 
(21 twin and 13 singleton pregnancies) resulted 
in preterm delivery (34/152, 22.3%), and out of 
all gestations, 37 (24.3%) were twin pregnancies. 
Eighty-six patients (56.5%) were delivered by 
cesarean section. The rest had normal vaginal 
delivery. 
Second-look hysteroscopy was performed in 
93.7% of the patients. Ninety-one out of 190 
(47.8%) women had a previous gestation, with only 
1 born baby.
The mean time between metroplasty and diagnosis 
of pregnancy was 8.7 months (1.54 – 39.3 months), 
with the earliest pregnancy being diagnosed at 
1.4 months. Out of the 152 total pregnancies, 146 
were achieved employing assisted reproductive 
technologies. From theses, 79 (51.9%) were part 
of the oocyte donation program (fresh and freeze-
thaw cycles). The other six patients accomplished 
pregnancy spontaneously (mean time to pregnancy 
after surgery 4.5 months). Ninety-six percent of 
gestations were achieved between 1 – 3 IVF cycles. 
Furthermore, 92% of the live births were born 
between 1 to 3 IVF cycles. With the practice of just 
1 IVF cycle, 88 (77.8%) pregnancies were obtained, 
with a mean time from surgery to gravidness of 6.5 
months. Additionally, 86 (76.1%) of the live births 
were from this subgroup. The data and reproductive 
outcomes corresponding to IVF cycles 1 to 3 are 
presented in Table II.
Discussion 
Congenital uterine anomalies have been implicated 
in women diagnosed with recurrent miscarriage 
and infertility (Serensen, 1988; Kupesic, 2001). 
According to the literature, although significant 
variation exists, the prevalence of congenital 
Müllerian anomalies in the infertile population is 
around 7.3% and 16.7% in those with recurrent 
miscarriage (Saravelos et al., 2008)
It is not clear whether there is a reasonable 
biological mechanism to link the presence of 
congenital Müllerian anomalies and diminished 
reproductive outcomes. Many attempts have 
been made to explain this phenomenon including 
follow-up visit approximately two months later, for 
assessment of surgical outcomes.
Statistics    
Data was obtained from SIVIS software (SAP 
systems, SIVIS Karlsruhe, Germany), and a database 
was created in Excel (Microsoft® Excel for Mac Ver. 
15.32. 2017. Redmond, WA). Statistical analysis 
was carried out with a statistical software program 
(SPSS 17.0.1 for Windows; SPSS, Chicago, IL).
Results 
The study included 190 women. The mean age 
and mean time of infertility were 36.8 years old 
± 11.5 and 4.3 years (1 – 15 years), respectively. 
Metroplasty was performed in women with RIF and 
a dysmorphic uterus. No cases of uterine perforation 
were seen, and no case of postoperative fever was 
recorded. There were no complications related to 
the fluid deficit during the procedure, and neither 
to blood loss. If considered appropriate, hyaluronic 
acid (Hyalobarrier®) was used in 40.5% (77/190) 
of patients immediately after surgery. All patients 
were discharged the same day. The total clinical 
pregnancy rate, the live birth rate, and the abortion 
rate were 80.0% (152/190), 77.3% (143/190) and 
11.1% (17/152), respectively (Table I). Interestingly, 
at 12 months, the clinical pregnancy rate was 76.3% 
(145/190) and at 6 months 50.5% (96/190). In other 
words, approximately 76% of total gravidities after 
the metroplasty were achieved during the first 12 




Patients (n) Mean age 
(years)
Pregnancies (n, %) Live births (n, %) Abortion (n, %)
Total “T” Shaped 190 36.8 152 (80.0) 147 (77.3) 17 (11.1)
Table I — Reproductive outcomes of patients with a dysmorphic uterus whom underwent hysteroscopic metroplasty
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IVF cycles after 
metroplasty
Patients (n) Pregnancies (n, %) Live births (n, %) Mean time 
to pregnancy 
(months)
1 113 88 (77.8) 86 (76.1) 6.5
2 48 38 (79.1) 36 (75.0) 11.6
3 16 15 (93.7) 14 (87.5) 14.2
Total (1-3) 177 141 (79.6) 136 (76.8) 6.56
Table II.—  Reproductive outcome after metroplasty with the use of 1 – 3 IVF cycles.
the study of implantation failure and recurrent 
abortion. However, no clear evidence has been 
yet identified (Chan et al., 2011; Fernandez et 
al., 2011). The etiology of reproductive failure in 
these women remains unclear. The mechanisms by 
which dysmorphic uteri cause infertility and early 
pregnancy loss have not been established. However, 
a recent systematic review and meta-analysis found 
the presence of congenital uterine anomalies to be 
associated with a reduced probability of pregnancy 
(equally for natural and ART cycles). Still, this 
conclusion only reached statistical significance when 
summing up both groups (Fernandez et al., 2011). In 
their systematic review, Chan and colleagues (2011) 
reported diminished fertility outcomes, increased 
rates of miscarriage and augmented preterm 
delivery rates, in patients with dysmorphic uteri 
(canalization defects), and arcuate uterus (superior 
third septum) was found explicitly associated with 
second-trimester miscarriage. 
Today we understand that a T-shaped uterus can 
also have a primary or an acquired origin (adhesions) 
( Fernandez et al., 2011). Historically, a T-shaped 
uterus has been related to a congenital malformation 
(DES exposure), and infertility has been reported to 
be more common in dysmorphic uteri compared to 
a normal uterine cavity. Thus, the results presented 
in this study are promising in regard to the 
improvement of the reproductive outcomes, and are 
consistent with prior evidence from other revisions 
of hysteroscopic metroplasty in the dysmorphic uteri 
(Nagel and Malo, 1993; Katz et al., 1996; Garbin 
et al., 1998; Fernandez et al., 2011). This study 
comprises a greater number of patients than those 
previously reported in the literature. Interestingly, 
and as opposed to many precedent publications, 
the present study shows how higher pregnancy 
and live birth rates are related to a first IVF cycle 
post-surgery. These values are 77.8% and 76.1%, 
respectively. The mean time to pregnancy was 
6.5 months. Likewise, the Kaplan-Meier life table 
analysis plot for pregnancies achieved per month 
showed how 86% gravidities were obtained between 
1 to 3 IVF cycles, with an associated live birth rate of 
76.8% and a mean time from metroplasty to surgery 
of 6.5 months. Although this is an observational 
study and no definitive conclusions could be drawn 
with this evidence, it shows a substantial relation 
between the metroplasty for dysmorphic uteri and 
promising reproductive outcomes (pregnancy and 
live birth rates). Furthermore, our findings are in line 
early studies published, on both, dysmorphic and in 
septate uteri, that presented successful outcomes 
(Nagel and Malo, 1993). Fedele et al. (1993) 
showed a cumulative pregnancy and birth rates at 
36 months, reaching 89% and 75%, with 80% in 
the septate uterus group and 67% in the subseptate 
uterus group. Other authors have published similar 
results (Katz et al., 1996; Fernandez et al., 2011). 
Hysteroscopic metroplasty was found to be a 
safe procedure. No intraoperative or postoperative 
complications and no associated morbidity were 
reported. Due to the deficiency of prospective, 
randomized, controlled trials, there is lack of 
consensus on whether infertility is an indication for 
metroplasty. However, this procedure has presented 
satisfactory results in pregnancy and live-birth rates 
at a global scale. Second-look hysteroscopy was 
performed in 93.7% of patients, and has proven  to 
be safe, demonstrating that metroplasty leds to good 
anatomical results, with the possibility to detect and 
treat possible adherences, as published by other 
authors (Fernandez et al., 2011; Ferro and Montoya, 
2016). 
Nevertheless, this actual data cannot demonstrate 
a causal-effect relationship between dysmorphic 
uteri and infertility.  Counting on its low morbidity 
and complication rate, plus, its successful 
practice, metroplasty should be considered to 
treat women with recurrent implantation failure 
due to dysmorphic uteri. There is dire need for a 
prospective, randomized, controlled study to support 
this evidence.
Conclusions
This study and our experience at the Instituto 
Valenciano de Infertilidad (IVI) put forward 
hysteroscopic metroplasty as a treatment to improve 
pregnancy and live birth rates in women diagnosed 
with a dysmorphic uterus, in particular those with a 
T-shaped uterus and history of recurrent implantation 
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failure. In line with the existent literature, the 
application of this procedure represents a safe 
method with minimal complication and morbidity 
rates. Although this is an observational study and 
no definitive conclusions can be drawn from this 
evidence, this publication illustrates a positive 
relation between hysteroscopic metroplasty for 
dysmorphic uteri and satisfactory reproductive 
outcomes [pregnancy and live birth rates]. However, 
prospective, randomized, controlled studies are 
needed to support these results.
Declaration of interests:
The authors report no declarations of interest and confirm 
that they have obtained the written permission from all 
patients whose case is being presented.
References
Bakas P, Gregoriou O, Hassiakos D et al. Hysteroscopic 
resection of uterine septum and reproductive outcome in 
women with unexplained infertility. Gynecol Obstet Invest. 
2012;73(4):321-5.
Bozdag G, Aksan G, Esinler I et al. What is the role of office 
hysteroscopy in women with failed IVF cycles? RBM 
Online. 2008;17(3):410-5.
Chan Y, Jayaprakasan K, Tan A et al. Reproductive outcomes 
in women with congenital uterine anomalies: a systematic 
review. Ultrasound Obstet Gynecol. 2011;38(4):371-82.
Coughlan C, Ledger W, Wang Q et al. Recurrent implantation 
failure: definition and management. RBM Online. 
2014;28(1):14-38.
Dalton VK, Saunders NA, Harris LH et al. Intrauterine adhesions 
after manual vacuum aspiration for early pregnancy failure. 
Fertil Steril. 2006;85(6):1823. e1-. e3.
Di Spiezio Sardo A, Campo R, Gordts S et al. The 
comprehensiveness of the ESHRE/ESGE classification 
of female genital tract congenital anomalies: a systematic 
review of cases not classified by the AFS system. Hum 
Reprod. 2015;30(5):1046-58.
Fedele L, Arcaini L, Parazzini F et al. Reproductive prognosis 
after hysteroscopic metroplasty in 102 women: life-table 
analysis. Fertil Steril. 1993;59(4):768-72.
Fernandez H, Garbin O, Castaigne V et al. Surgical approach 
to and reproductive outcome after surgical correction of a 
T-shaped uterus. Hum Reprod. 2011;26(7):1730-4.
Ferro J, Montoya P. Innovative Alternatives in the Postoperative 
Management of Asherman Syndrome. In: Deshmukh SS, O., 
editor. Mastering the Techniques in Hysteroscopy. First ed. 
India: Jaypee; 2016. p. 431-7.
Garbin O, Ohl J, Bettahar-Lebugle K et al. Hysteroscopic 
metroplasty in diethylstilboestrol-exposed and hypoplastic 
uterus: a report on 24 cases. Hum Reprod. 1998;13(10):2751-5.
Ghahiry AA, Aliabadi ER, Taherian AA et al. Effectiveness 
of hysteroscopic repair of uterine lesions in reproductive 
outcome. Int J Fertil Steril. 2014;8(2):129.
Grimbizis GF, Gordts S, Sardo ADS et al. The ESHRE–ESGE 
consensus on the classification of female genital tract 
congenital anomalies. Gynecol Surg. 2013;10(3):199-212.
